IVF Provider's Profit Falls, Sees a Dip in New Cycles

IVF provider sees new life in stimulated cycle numbers

A fertility services provider has reported a sharp fall in net profit after fewer patients started new treatment...

Monash IVF plans rebirth after embryo mix-ups smash profits

The IVF provider says it is clawing back market share and expects earnings to improve this year after damaging embryo mix-ups hurt investor confidence in 2025.

IVF provider's profit falls, sees a dip in new cycles

A fertility services provider has reported a sharp fall in net profit after fewer women started new treatment cycles, but says the business is improving.

Monash IVF Group earnings: FY26 profit slips, outlook improves

The Monash IVF Group Ltd (ASX: MVF) share price is in focus as the company posts FY26 revenue of $269.5 million and declares a final fully franked dividend, despite a 41% fall in underlying net profit after tax (NPAT). What did Monash IVF Group report? Revenue of $269.5 million, down 0.9% from FY25 Underlying EBITDA of $53.4 million, down 19.5% Underlying NPAT of $16.1 million, down 41.2% Reported EBITDA of $43.5 million; reported NPAT of $8.3 …

Health Check: Monash IVF misses profit guidance, but promises a rebirth

Assisted reproduction leader Monash IVF fell short of full-year guidance, but reports of a second-half turnaround buoyed investors. ... The post Health Check: Monash IVF misses profit guidance, but promises a rebirth   appeared first on Stockhead.